Full Text View
Tabular View
No Study Results Posted
Related Studies
Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia
This study is ongoing, but not recruiting participants.
Study NCT01109264   Information provided by Jiangsu Simcere Pharmaceutical R&D Co. Ltd.

First Received on April 19, 2010.   Last Updated on May 18, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Lymphocytic Leukemia
Additional conditions recognized in this trial
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Leukemia, B-Cell
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
Chlorambucil
Additional drug interventions recognized in this trial
Bendamustine
Nitrogen Mustard Compounds
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Jiangsu Simcere Pharmaceutical R&D Co. Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services